F-group (family)
5.1.3.5 HN
Ligands and drugs
197
Member domains
147
with ligand contacts (≤ 4 Å)
74.6% of members
122
with DrugDomain annotations
61.9% of members
120
with a DrugBank compound
60.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 5.1.3.5 belongs to X-group 5 beta-propeller-like, which binds 7.8 ligand superclasses per 20 proteins, broader than 52% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 112 |
| DB03991 | DAN | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid | 13 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 4 |
| DB04265 | SLB | N-acetyl-beta-neuraminic acid | 4 |
| DB00558 | ZMR | Zanamivir | 2 |
| DB03721 | SIA | N-acetyl-alpha-neuraminic acid | 2 |
| DB04211 | FSI | 5-(acetylamino)-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 2 |
| DB04699 | GBL | gamma-Butyrolactone | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 124 |
| CAmetal | CALCIUM ION | 48 |
| DAN | 2-DEOXY-2,3-DEHYDRO-N-ACETYL-NEURAMINIC ACID | 13 |
| CL | CHLORIDE ION | 6 |
| ZNmetal | ZINC ION | 5 |
| SLB | N-acetyl-beta-neuraminic acid | 4 |
| 6Y6 | 2,6-anhydro-3,4,5-trideoxy-4-[4-(methoxymethyl)-1H-1,2,3-triazol-1-yl]-5-[(2-methylpropanoyl)amino]-D-glycero-D-galacto-non-2-enonic acid | 2 |
| 8LM | 2,6-anhydro-3,5-dideoxy-5-[(2-methylpropanoyl)amino]-3-(4-phenyl-1H-1,2,3-triazol-1-yl)-D-glycero-D-galacto-non-2-enonic acid | 2 |
| DF4 | (3R,4R,5R,6R)-5-(acetylamino)-3-fluoro-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4,5,6-tetrahydropyranium-2-carboxylate | 2 |
| FSI | 5-acetamido-3,5-dideoxy-3-fluoro-D-erythro-alpha-L-manno-non-2-ulopyranosonic acid | 2 |
| GBL | GAMMA-BUTYROLACTONE | 2 |
| NDG | 2-acetamido-2-deoxy-alpha-D-glucopyranose | 2 |
| OEL | (6R)-2,6-anhydro-3,4,5-trideoxy-6-[(2S)-2,3-dihydroxypropanoyl]-3-fluoro-5-[(2-methylpropanoyl)amino]-4-triaza-1,2-dien-2-ium-1-yl-L-gulonic acid | 2 |
| SFJ | (2R,3R,4R,5R,6R)-5-acetamido-2,3-difluoro-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]tetrahydro-2H-pyran-2-carboxylicacid | 2 |
| SIA | N-acetyl-alpha-neuraminic acid | 2 |
| ZMR | ZANAMIVIR | 2 |
| BMA | beta-D-mannopyranose | 1 |
| I57 | 2,6-anhydro-3,4,5-trideoxy-5-[(2-methylpropanoyl)amino]-4-(4-phenyl-1H-1,2,3-triazol-1-yl)-D-glycero-D-galacto-non-2-enonic acid | 1 |
| IOD | IODIDE ION | 1 |
| MAN | alpha-D-mannopyranose | 1 |